000 | 01919 a2200553 4500 | ||
---|---|---|---|
005 | 20250517135937.0 | ||
264 | 0 | _c20180411 | |
008 | 201804s 0 0 eng d | ||
022 | _a1875-5828 | ||
024 | 7 |
_a10.2174/1567205014666170207093455 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheng, Jinbo | |
245 | 0 | 0 |
_aVitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice. _h[electronic resource] |
260 |
_bCurrent Alzheimer research _c2017 |
||
300 |
_a820-833 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAging _xdrug effects |
650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xmetabolism |
650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xmetabolism |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCathepsin B _xmetabolism |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xmetabolism |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
650 | 0 | 4 | _aResveratrol |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aStilbenes _xpharmacology |
650 | 0 | 4 |
_aVitamin D _xblood |
650 | 0 | 4 |
_atau Proteins _xmetabolism |
700 | 1 | _aRui, Yehua | |
700 | 1 | _aQin, Liqiang | |
700 | 1 | _aXu, Jiaying | |
700 | 1 | _aHan, Shufen | |
700 | 1 | _aYuan, Linxi | |
700 | 1 | _aYin, Xuebin | |
700 | 1 | _aWan, Zhongxiao | |
773 | 0 |
_tCurrent Alzheimer research _gvol. 14 _gno. 8 _gp. 820-833 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1567205014666170207093455 _zAvailable from publisher's website |
999 |
_c26861006 _d26861006 |